Litigation
Nov. 17, 2010
Biotech Exec's Sentence Questioned
A federal judge on Monday ordered prosecutors in an off-label drug marketing case back to the drawing board, expressing skepticism at the 10-year prison sentence they are seeking for a former chief executive of a biopharmaceutical company.
Daily Journal Staff Writer
SAN FRANCISCO - A federal judge on Monday ordered prosecutors in an off-label drug marketing case back to the drawing board, expressing skepticism at the 10-year prison sentence they are seeking for a former chief executive of a biopharmaceutical company.
U.S. Senior District Judge Marilyn H. Patel said she was not persuaded by the government's contention that Dr. W. Scott Harkonen's crime le...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In